Recent developments include the appointment of a new CFO at Iron Horse Acquisitions Corp., the parent company involved in the business combination with CN Healthy Food Tech Group Corp. The company continues to face regulatory and listing challenges including a Nasdaq trading halt and delisting appeal.

• Iron Horse Acquisitions Corp. appointed a new Chief Financial Officer as reported on October 28, 2024 [N1].
• The company’s securities remain halted on Nasdaq since October 1, 2025, pending regulatory review by the China Securities Regulatory Commission [S2].
• In July 2026, the company received a delisting determination letter from Nasdaq and has filed an appeal to the Nasdaq Hearings Panel [S2].
• The company paid administrative fines imposed by the CSRC in May 2026 related to offshore listing filing violations [S2].
• Three promissory notes remain in default as of June 30, 2026, with discussions ongoing with note holders to address defaults and maturity extensions [S2].

The company has demonstrated revenue growth and profitability in a relatively short operational period since May 2024, supported by a diversified product portfolio in the health and wellness sector. Its marketing strategy combines digital and traditional channels to build a distributor and customer base. The company maintains strong liquidity with a current ratio above 2 and positive net income in recent quarters. Its intellectual property assets including patents and trademarks support product differentiation. The ongoing appeal against Nasdaq’s delisting decision and resolution of regulatory issues could stabilize its market access. The company’s focus on blending traditional Chinese medicine with modern health foods aligns with growing consumer demand for natural wellness products.

The company faces significant regulatory challenges including a prolonged Nasdaq trading halt since October 2025 and a delisting determination with uncertain outcome. Administrative penalties from the CSRC for offshore listing filing violations highlight compliance risks. The company has defaulted promissory notes with accrued default interest and conversion provisions that could lead to substantial dilution of existing shareholders. Its reliance on OEM suppliers exposes it to supply chain disruptions and inventory management risks. The regulatory environment in China imposes restrictions on cash transfers and dividend payments, potentially limiting financial flexibility. The trading halt and delisting risks may adversely affect reputation, customer and supplier relationships, and overall business prospects.

CN Healthy Food Tech Group Corp. operates in a niche segment of the health and wellness food industry in China, combining traditional Chinese medicine with modern nutritional products. Its business model leverages a distributor network and live-stream sales channels, supported by digital marketing and partnerships. The company’s reliance on OEM suppliers rather than in-house production limits vertical integration advantages. The regulatory environment in China and the company’s recent compliance issues with the CSRC present significant barriers and risks to competitors and new entrants. The company’s established trademarks, patents, and product portfolio contribute to intellectual property protection. However, the trading halt and delisting risks may impact its market presence and investor confidence, affecting its competitive positioning.

• Regulatory and Listing Risks: The company’s securities have been halted from trading on Nasdaq since October 2025 due to CSRC review. A delisting determination was issued in July 2026, with an appeal pending. Failure to maintain listing could impact liquidity and trigger contractual defaults.
• CSRC Administrative Penalties: The company and its CEO were fined by the China Securities Regulatory Commission for failure to complete mandatory offshore listing filing procedures. This may affect regulatory relationships and business operations in China.
• Defaulted Promissory Notes and Dilution Risk: Three promissory notes remain in default with principal of approximately $3.5 million plus accrued interest. Conversion provisions could lead to significant dilution if enforced.
• Supply Chain and Inventory Risks: Dependence on OEM suppliers for production exposes the company to risks of delays, shortages, and quality issues. Distributor inventory management also affects product availability and sales.
• Capital and Liquidity Constraints: Restrictions on transferring cash out of China and dividend payments from PRC subsidiaries may limit financial flexibility. The company’s ability to raise additional capital is uncertain.

• CN Healthy Food Tech Group Corp. operates primarily in China through wholly owned subsidiaries focusing on health and wellness food products, including natural, grain-based health foods blending modern technology with traditional Chinese medicine [S1].
• The company commenced operations in May 2024 and offers products such as Shangshan Suyang Porridge, plant-based essential oils, collagen peptide prebiotics, natto compound gummy supplements, and similar health-related products [S1].
• Revenue is generated mainly from two segments: wholesale distribution of inventories to distributors and live-stream sales of digital coupons redeemable at third-party merchants [S1].
• The company acts as principal in sales transactions, bearing inventory risk and setting prices, recognizing revenue at the point of transfer of control to customers or coupon redemption [S1].
• Marketing efforts include digital and offline channels such as social media, keyword campaigns, affiliate programs, influencer partnerships, and traditional media to attract and retain distributors and customers [S1].
• The company does not have in-house production and relies entirely on OEM suppliers for raw materials and finished products, exposing it to supplier risks including delays and shortages [S1].
• As of June 30, 2026, the company reported cash and cash equivalents of approximately $23.3 million, current assets of $27.5 million, current liabilities of $11.7 million, resulting in a current ratio of 2.35 and a cash ratio of 1.99, indicating liquidity [S2].
• For the quarter ended June 30, 2026, revenue was approximately $8.7 million and net income was about $3.1 million, with basic and diluted EPS of $0.06 [S2].
• The company has outstanding promissory notes in default with aggregate principal around $3.5 million plus accrued default interest, some convertible into common stock, posing dilution risk [S2].
• The company’s common stock and warrants have been halted from trading on Nasdaq since October 1, 2025, due to regulatory review by the China Securities Regulatory Commission (CSRC) [S2].
• The company received a delisting determination letter from Nasdaq in July 2026 and has appealed; the trading halt remains in effect [S2].
• The CSRC imposed administrative penalties on the company’s PRC subsidiary and CEO for failure to complete mandatory offshore listing filing procedures prior to Nasdaq listing, with fines paid in May 2026 [S2].
• The company’s business is subject to risks related to regulatory compliance in China, including capital controls affecting cash transfers and dividend payments from PRC subsidiaries [S2].
• The company’s marketing and sales strategy focuses on acquiring and retaining distributors and local merchants, balancing liquidity preservation with growth efforts [S1].
• The company’s financial disclosures include detailed revenue recognition policies, cost of revenue, operating expenses, and other income components [S1].
• Recent news includes the appointment of a new CFO at Iron Horse Acquisitions Corp., the parent company involved in the business combination with CN Healthy Food Tech Group Corp. [N1].